Master’s Program in Hematology and Oncology for Hospital Pharmacy

Advanced Training for Hospital Pharmacists

The Master’s Program in Hematology and Oncology for Hospital Pharmacy is a 60-ECTS postgraduate program delivered online. It is intended for hospital pharmacists with at least three years of experience in oncology pharmacy. The program includes 13 academic modules and a master’s thesis, with enrollment capped at 40 students.

Curriculum

Coursework covers response criteria and outcomes in hematologic oncology, pharmaceutical care, supportive treatment, multiple myeloma and other monoclonal gammopathies, acute and chronic leukemias, Hodgkin and non-Hodgkin lymphomas, pediatric hematologic cancers, cellular therapies such as CAR T, stem-cell transplantation, and hematogeriatrics.

Faculty and Academic Leadership

The program’s scientific committee and faculty include specialists in hematology and hospital pharmacy from Spanish hospitals and oncology centers. The Spanish program profile names Miguel Ángel Ortega of the University of Alcalá’s Department of Medicine and Medical Specialties as academic director and Estela Moreno Martínez of Hospital de la Santa Creu i Sant Pau as scientific director.

Current Cohort

The listed cohort runs from March 2026 through April 2027, with admissions listed for December 2025 through January 2026. These dates describe the cohort in the available program profile.